Market Overview: Bradykinin B1 Receptor (B1R) – Pipeline Review, H1 2016


The report ” Bradykinin B1 Receptor (B1R) – Pipeline Review, H1 2016 “, has been prepared based on an in-depth market analysis with inputs from industry experts.

Global Markets Directs, Bradykinin B1 Receptor (B1R) – Pipeline Review, H1 2016, provides in depth analysis on Bradykinin B1 Receptor (B1R) targeted pipeline therapeutics.

The report provides comprehensive information on the Bradykinin B1 Receptor (B1R) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Bradykinin B1 Receptor (B1R) targeted therapeutics development and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report @


– The report provides a snapshot of the global therapeutic landscape for Bradykinin B1 Receptor (B1R)

– The report reviews Bradykinin B1 Receptor (B1R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved in Bradykinin B1 Receptor (B1R) targeted therapeutics and enlists all their major and minor projects

– The report assesses Bradykinin B1 Receptor (B1R) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news and deals related to Bradykinin B1 Receptor (B1R) targeted therapeutics

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand the targeted therapy areas and indications for Bradykinin B1 Receptor (B1R)

– Identify the use of drugs for target identification and drug repurposing

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Bradykinin B1 Receptor (B1R) development landscape

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Browse All reports Of this Category:

Table of Content :

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Bradykinin B1 Receptor (B1R) Overview 6

Therapeutics Development 7

Bradykinin B1 Receptor (B1R) – Products under Development by Stage of Development 7

Bradykinin B1 Receptor (B1R) – Products under Development by Therapy Area 8

Bradykinin B1 Receptor (B1R) – Products under Development by Indication 9

Bradykinin B1 Receptor (B1R) – Pipeline Products Glance 10

Early Stage Products 10

Bradykinin B1 Receptor (B1R) – Products under Development by Companies 11

Bradykinin B1 Receptor (B1R) – Products under Development by Universities/Institutes 13

Bradykinin B1 Receptor (B1R) – Therapeutics Assessment 15

Assessment by Monotherapy/Combination Products 15

Assessment by Mechanism of Action 16

Assessment by Route of Administration 17

Assessment by Molecule Type 18

Bradykinin B1 Receptor (B1R) – Companies Involved in Therapeutics Development 20

Axxam SpA 20

Boehringer Ingelheim GmbH 21

Dompe Farmaceutici S.p.A. 22

Grunenthal GmbH 23

Bradykinin B1 Receptor (B1R) – Drug Profiles 24

BI-113823 – Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

Drug to Antagonize Bradykinin Receptor B1 for Lupus Nephritis – Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

Small Molecule to Antagonize Bradykinin B1 Receptor for Chronic Inflammation – Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

Small Molecules to Antagonize BDKRB1 for Pain and Ophthalmic Disorders – Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us:

Mr. Nachiket

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA: Canada Toll Free: 866-997-4948


E :